Skip to main content
Top
Published in: Diabetologia 12/2011

01-12-2011 | Article

Racial and ethnic disparities in diabetes risk after gestational diabetes mellitus

Authors: A. H. Xiang, B. H. Li, M. H. Black, D. A. Sacks, T. A. Buchanan, S. J. Jacobsen, J. M. Lawrence

Published in: Diabetologia | Issue 12/2011

Login to get access

Abstract

Aims/hypothesis

To investigate racial/ethnic disparities in diabetes risk after gestational diabetes mellitus (GDM).

Methods

This is a retrospective cohort study of women enrolled in the Kaiser Permanente Southern California health plan from 1995 to 2009. GDM status was identified on the basis of plasma glucose levels during pregnancy. The incidence of diabetes after the first delivery complicated by GDM before 31 December 2009 (n = 12,998) was compared with the experience for women without GDM (n = 64,668) matched on maternal age at delivery, race/ethnicity and year of delivery (1:5 ratio). Matched Cox regression was used to compare the RRs of diabetes associated with GDM within and across racial/ethnic groups.

Results

Compared with the women without GDM, the HRs (95% CI) of diabetes for women after GDM were 6.5 (5.2, 8.0) in non-Hispanic white, 7.7 (6.8, 8.7) in Hispanic, 9.9 (7.5, 13.1) in black and 6.3 (5.0, 7.9) in Asian/Pacific Islanders after adjustment for parity, maternal education, comorbidity and number of outpatient visits before the index pregnancy. The HR of diabetes for black women was significantly higher than that for non-Hispanic white women (p = 0.032). Further adjustment for prepregnancy BMI reduced the diabetes risk association with GDM for each racial/ethnic group, but did not explain the risk differences across groups.

Conclusions/interpretations

Racial/ethnic disparities exist in risk of diabetes after GDM. Black women with GDM had the highest risk of developing diabetes. This highlights the importance of developing an effective diabetes screening and prevention programme in women with GDM, particularly black women with GDM.
Literature
1.
go back to reference American Diabetes Association (2011) Standards of medical care in diabetes—2011. Diabetes Care 34(Suppl 1):S11–S61CrossRef American Diabetes Association (2011) Standards of medical care in diabetes—2011. Diabetes Care 34(Suppl 1):S11–S61CrossRef
2.
go back to reference Buchanan TA, Xiang A, Kjos SL, Watanabe R (2007) What is gestational diabetes? Diabetes Care 30(Suppl 2):S105–S111PubMedCrossRef Buchanan TA, Xiang A, Kjos SL, Watanabe R (2007) What is gestational diabetes? Diabetes Care 30(Suppl 2):S105–S111PubMedCrossRef
3.
go back to reference Berkowitz GS, Lapinski RH, Wein R, Lee D (1992) Race/ethnicity and other risk factors for gestational diabetes. Am J Epidemiol 135:965–973PubMed Berkowitz GS, Lapinski RH, Wein R, Lee D (1992) Race/ethnicity and other risk factors for gestational diabetes. Am J Epidemiol 135:965–973PubMed
4.
go back to reference Lawrence JM, Contreras R, Chen W, Sacks DA (2008) Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999–2005. Diabetes Care 31:899–904PubMedCrossRef Lawrence JM, Contreras R, Chen W, Sacks DA (2008) Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999–2005. Diabetes Care 31:899–904PubMedCrossRef
5.
go back to reference Hedderson MM, Darbinian JA, Ferrara A (2010) Disparities in the risk of gestational diabetes by race–ethnicity and country of birth. Paediatr Perinat Epidemiol 24:441–448PubMedCrossRef Hedderson MM, Darbinian JA, Ferrara A (2010) Disparities in the risk of gestational diabetes by race–ethnicity and country of birth. Paediatr Perinat Epidemiol 24:441–448PubMedCrossRef
6.
go back to reference Ferrara A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM (2004) An increase in the incidence of gestational diabetes mellitus: Northern California, 1991–2000. Obstet Gynecol 103:526–533PubMedCrossRef Ferrara A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM (2004) An increase in the incidence of gestational diabetes mellitus: Northern California, 1991–2000. Obstet Gynecol 103:526–533PubMedCrossRef
7.
go back to reference Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS (2005) Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28:579–584PubMedCrossRef Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS (2005) Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28:579–584PubMedCrossRef
8.
go back to reference Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:1862–1868PubMedCrossRef Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25:1862–1868PubMedCrossRef
9.
go back to reference Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA (1995) Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes 44:586–591PubMedCrossRef Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA (1995) Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes 44:586–591PubMedCrossRef
10.
go back to reference Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373:1773–1779PubMedCrossRef Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373:1773–1779PubMedCrossRef
11.
go back to reference Association AD (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–S69CrossRef Association AD (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–S69CrossRef
12.
go back to reference Rubin DB (1987) Multiple imputation for nonresponse in surveys. Wiley, New YorkCrossRef Rubin DB (1987) Multiple imputation for nonresponse in surveys. Wiley, New YorkCrossRef
13.
go back to reference Feig DS, Zinman B, Wang X, Hux JE (2008) Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 179:229–234PubMedCrossRef Feig DS, Zinman B, Wang X, Hux JE (2008) Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 179:229–234PubMedCrossRef
14.
go back to reference Xiang AH, Kjos SL, Takayanagi M, Trigo E, Buchanan TA (2010) Detailed physiological characterization of the development of type 2 diabetes in Hispanic women with prior gestational diabetes mellitus. Diabetes 59:2625–2630PubMedCrossRef Xiang AH, Kjos SL, Takayanagi M, Trigo E, Buchanan TA (2010) Detailed physiological characterization of the development of type 2 diabetes in Hispanic women with prior gestational diabetes mellitus. Diabetes 59:2625–2630PubMedCrossRef
Metadata
Title
Racial and ethnic disparities in diabetes risk after gestational diabetes mellitus
Authors
A. H. Xiang
B. H. Li
M. H. Black
D. A. Sacks
T. A. Buchanan
S. J. Jacobsen
J. M. Lawrence
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2330-2

Other articles of this Issue 12/2011

Diabetologia 12/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine